{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T19:43:27Z","timestamp":1781898207013,"version":"3.54.5"},"reference-count":43,"publisher":"SAGE Publications","issue":"4","license":[{"start":{"date-parts":[[2019,12,12]],"date-time":"2019-12-12T00:00:00Z","timestamp":1576108800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2019,12,12]]},"DOI":"10.3233\/jad-190475","type":"journal-article","created":{"date-parts":[[2019,10,29]],"date-time":"2019-10-29T14:48:17Z","timestamp":1572360497000},"page":"1059-1075","source":"Crossref","is-referenced-by-count":10,"title":["Abnormalities of DYRK1A-Cytoskeleton Complexes in the Blood Cells as Potential Biomarkers of Alzheimer\u2019s Disease"],"prefix":"10.1177","volume":"72","author":[{"given":"Karol","family":"Dowjat","sequence":"first","affiliation":[{"name":"Department of Developmental Neurobiology, New York State Institute for Basic Research in Developmental Disabilities, Staten Island, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatyana","family":"Adayev","sequence":"additional","affiliation":[{"name":"Department of Genetics, New York State Institute for Basic Research in Developmental Disabilities, Staten Island, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urszula","family":"Wojda","sequence":"additional","affiliation":[{"name":"Laboratory of Preclinical Testing of Higher Standard, Neurobiology Center, Nencki Institute of Experimental Biology, Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Brzozowska","sequence":"additional","affiliation":[{"name":"Laboratory of Preclinical Testing of Higher Standard, Neurobiology Center, Nencki Institute of Experimental Biology, Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Barczak","sequence":"additional","affiliation":[{"name":"Department of Neurodegenerative Disorders, Mossakowski Medical Research Centre, Polish Academy of Sciences, Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Gabryelewicz","sequence":"additional","affiliation":[{"name":"Department of Neurodegenerative Disorders, Mossakowski Medical Research Centre, Polish Academy of Sciences, Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Wen","family":"Hwang","sequence":"additional","affiliation":[{"name":"Department of Molecular Biology, New York State Institute for Basic Research in Developmental Disabilities, Staten Island, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-190475_ref1","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1007\/s00018-009-0123-2","article-title":"Function and regulation of Dyrk1A: towards understanding Down syndrome","volume":"66","author":"Park","year":"2009","journal-title":"Cell Mol Life Sci"},{"key":"10.3233\/JAD-190475_ref2","doi-asserted-by":"crossref","first-page":"244","DOI":"10.5607\/en.2013.22.4.244","article-title":"New perspectives of Dyrk1A role in neurogenesis and neuropathologic features of Down syndrome","volume":"22","author":"Park","year":"2013","journal-title":"Exp Neurobiol"},{"key":"10.3233\/JAD-190475_ref3","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1742-4658.2010.07954.x","article-title":"MNB\/DYRK1A as a multiple regulator of neuronal development","volume":"278","author":"Tejedor","year":"2011","journal-title":"FEBS J"},{"key":"10.3233\/JAD-190475_ref4","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/emmm.201302848","article-title":"Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21","volume":"6","author":"Hibaoui","year":"2014","journal-title":"EMBO Mol Med"},{"key":"10.3233\/JAD-190475_ref5","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1399-0004.2010.01544.x","article-title":"Intragenic deletion in DYRK1A leads to mental retardation and primary microcephaly","volume":"79","author":"van Bon","year":"2011","journal-title":"Clin Genet"},{"key":"10.3233\/JAD-190475_ref6","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.ajhg.2008.03.001","article-title":"Truncation of the Down syndrome candidate gene DYRK1A in two unrelated patients with microcephaly","volume":"82","author":"Moller","year":"2008","journal-title":"Am J Hum Genet"},{"key":"10.3233\/JAD-190475_ref7","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ejmg.2014.12.014","article-title":"DYRK1A mutations in two unrelated patients","volume":"58","author":"Ruaud","year":"2015","journal-title":"Eur J Med Genet"},{"key":"10.3233\/JAD-190475_ref8","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1136\/jmedgenet-2012-101251","article-title":"The DYRK1A gene is a cause of syndromic intellectual disability with severe microcephaly and epilepsy","volume":"49","author":"Courcet","year":"2012","journal-title":"J Med Genet"},{"key":"10.3233\/JAD-190475_ref9","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1038\/ejhg.2015.71","article-title":"DYRK1A haploinsufficiency causes a new recognizable syndrome with microcephaly, intellectual disability, speech impairment, and distinct facies","volume":"23","author":"Ji","year":"2015","journal-title":"Eur J Hum Genet"},{"key":"10.3233\/JAD-190475_ref10","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1038\/ejhg.2015.29","article-title":"Ten new cases further delineate the syndromic intellectual disability phenotype caused by mutations in DYRK1A","volume":"23","author":"Bronicki","year":"2015","journal-title":"Eur J Hum Genet"},{"key":"10.3233\/JAD-190475_ref11","first-page":"997","article-title":"Possible narrowed assignment of the loci of monosomy 21-associated microcephaly and intrauterine growth retardation to a 1.2-Mb segment at 21q22.2","volume":"60","author":"Matsumoto","year":"1997","journal-title":"Am J Hum Genet"},{"key":"10.3233\/JAD-190475_ref12","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1002\/ajmg.a.33228","article-title":"Microdeletion of the Down syndrome critical region at 21q22","volume":"152A","author":"Fujita","year":"2010","journal-title":"Am J Med Genet A"},{"key":"10.3233\/JAD-190475_ref13","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/ajmg.a.33735","article-title":"Clinical manifestations of the deletion of Down syndrome critical region including DYRK1A and KCNJ6","volume":"155","author":"Yamamoto","year":"2011","journal-title":"Am J Med Genet Part A"},{"key":"10.3233\/JAD-190475_ref14","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1159\/000320113","article-title":"Distinctive phenotypic abnormalities associated with submicroscopic 21q22 deletion including DYRK1A","volume":"1","author":"Oegema","year":"2010","journal-title":"Mol Syndromol"},{"key":"10.3233\/JAD-190475_ref15","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12881-016-0276-4","article-title":"Case report of novel DYRK1A mutations in 2 individuals with syndromic intellectual disability and a review of the literature","volume":"17","author":"Luco","year":"2016","journal-title":"BMC Med Genet"},{"key":"10.3233\/JAD-190475_ref16","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1096\/fj.10-165837","article-title":"DYRK family of protein kinases: evolutionary relationships, biochemical properties, and functional roles","volume":"25","author":"Aranda","year":"2011","journal-title":"FASEB J"},{"key":"10.3233\/JAD-190475_ref17","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1093\/cercor\/bhr362","article-title":"Dyrk1A influences neuronal morphogenesis through regulation of cytoskeletal dynamics in mammalian cortical neurons","volume":"22","author":"Martinez de Lagran","year":"2012","journal-title":"Cereb Cortex"},{"key":"10.3233\/JAD-190475_ref18","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1002\/cm.21021","article-title":"Dyrk kinases regulate phosphorylation of doublecortin, cytoskeletal organization, and neuronal morphology","volume":"69","author":"Slepak","year":"2012","journal-title":"Cytoskeleton (Hoboken)"},{"key":"10.3233\/JAD-190475_ref19","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1242\/jcs.086124","article-title":"Dyrk1A negatively regulates the actin cytoskeleton through threonine phosphorylation of N-WASP","volume":"125","author":"Park","year":"2012","journal-title":"J Cell Sci"},{"key":"10.3233\/JAD-190475_ref20","doi-asserted-by":"crossref","first-page":"R26","DOI":"10.1186\/gb-2009-10-3-r26","article-title":"Parallel RNAi screens across different cell lines identify generic and cell type-specific regulators of actin organization and cell morphology","volume":"10","author":"Liu","year":"2009","journal-title":"Genome Biol"},{"key":"10.3233\/JAD-190475_ref21","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1097\/NEN.0b013e31827733c8","article-title":"Gene dosage-dependent association of DYRK1A with the cytoskeleton in the brain and lymphocytes of down syndrome patients","volume":"71","author":"Dowjat","year":"2012","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.3233\/JAD-190475_ref22","doi-asserted-by":"crossref","first-page":"917","DOI":"10.2217\/bmm-2017-0041","article-title":"Search for Alzheimer\u2019s disease biomarkers in blood cells: hypotheses-driven approach","volume":"11","author":"Wojsiat","year":"2017","journal-title":"Biomark Med"},{"key":"10.3233\/JAD-190475_ref23","doi-asserted-by":"crossref","first-page":"5683","DOI":"10.1007\/s12035-016-0105-y","article-title":"Familial Alzheimer\u2019s disease lymphocytes respond differently than sporadic cells to oxidative stress: upregulated p53-p21 signaling linked with presenilin 1 mutants","volume":"54","author":"Wojsiat","year":"2017","journal-title":"Mol Neurobiol"},{"key":"10.3233\/JAD-190475_ref24","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-190475_ref25","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","article-title":"The diagnosis of mild cognitive impairment due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"Albert","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-190475_ref26","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3233\/JAD-160176","article-title":"Association between cerebrospinal fluid biomarkers for Alzheimer\u2019s disease, APOE genotypes and auditory verbal learning task in subjective cognitive decline, mild cognitive impairment, and Alzheimer\u2019s disease","volume":"54","author":"Mandecka","year":"2016","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-190475_ref27","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/jnr.23279","article-title":"Intracellular distribution of differentially phosphorylated dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A)","volume":"92","author":"Kaczmarski","year":"2014","journal-title":"J Neurosci Res"},{"key":"10.3233\/JAD-190475_ref28","doi-asserted-by":"crossref","first-page":"9297","DOI":"10.1021\/bi9010557","article-title":"Dyrk1A binds to multiple endocytic proteins required for formation of clathrin-coated vesicles","volume":"48","author":"Murakami","year":"2009","journal-title":"Biochemistry"},{"key":"10.3233\/JAD-190475_ref29","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.neuroscience.2011.08.028","article-title":"Form of dual-specificity tyrosine-(Y)-phosphorylation-regulated kinase 1A nonphosphorylated at tyrosine 145 and 147 is enriched in the nuclei of astroglial cells, adult hippocampal progenitors, and some cholinergic axon terminals","volume":"195","author":"Kida","year":"2011","journal-title":"Neuroscience"},{"key":"10.3233\/JAD-190475_ref30","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1385\/JMN:17:2:225","article-title":"Lewy body pathology in Alzheimer\u2019s disease","volume":"17","author":"Kotzbauer","year":"2001","journal-title":"J Mol Neurosci"},{"key":"10.3233\/JAD-190475_ref31","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/ana.21706","article-title":"The neuropathology of probable Alzheimer disease and mild cognitive impairment","volume":"66","author":"Schneider","year":"2009","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-190475_ref32","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/00002093-199709000-00009","article-title":"Studies in a large family with late-onset Alzheimer disease (LOAD)","volume":"11","author":"Martin","year":"1997","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.3233\/JAD-190475_ref33","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13195-019-0485-0","article-title":"Advantages and disadvantages of the use of the CSF Amyloid beta (Abeta) 42\/40 ratio in the diagnosis of Alzheimer\u2019s Disease","volume":"11","author":"Hansson","year":"2019","journal-title":"Alzheimers Res Ther"},{"key":"10.3233\/JAD-190475_ref34","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1001\/jamaneurol.2015.0607","article-title":"Targeting prodromal Alzheimer disease with avagacestat: a randomized clinical trial","volume":"72","author":"Coric","year":"2015","journal-title":"JAMA Neurol"},{"key":"10.3233\/JAD-190475_ref35","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1242\/jcs.040162","article-title":"Nonprimed and DYRK1A-primed GSK3 beta-phosphorylation sites on MAP1B regulate microtubule dynamics in growing axons","volume":"122","author":"Scales","year":"2009","journal-title":"J Cell Sci"},{"key":"10.3233\/JAD-190475_ref36","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.neuron.2016.03.027","article-title":"Phosphorylation of beta-tubulin by the Down syndrome kinase, minibrain\/DYRK1a, regulates microtubule dynamics and dendrite morphogenesis","volume":"90","author":"Ori-McKenney","year":"2016","journal-title":"Neuron"},{"key":"10.3233\/JAD-190475_ref37","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3389\/fnbeh.2016.00104","article-title":"DYRK1A, a dosage-sensitive gene involved in neurodevelopmental disorders, is a target for drug development in Down syndrome","volume":"10","author":"Duchon","year":"2016","journal-title":"Front Behav Neurosci"},{"key":"10.3233\/JAD-190475_ref38","doi-asserted-by":"crossref","first-page":"e425","DOI":"10.1038\/tp.2014.61","article-title":"Plasma DYRK1A as a novel risk factor for Alzheimer\u2019s disease","volume":"4","author":"Janel","year":"2014","journal-title":"Transl Psychiatry"},{"key":"10.3233\/JAD-190475_ref39","doi-asserted-by":"crossref","first-page":"519","DOI":"10.2174\/1567205011666140618103827","article-title":"Biomarkers of Alzheimer\u2019s disease risk in peripheral tissues; focus on buccal cells","volume":"11","author":"Francois","year":"2014","journal-title":"Curr Alzheimer Res"},{"key":"10.3233\/JAD-190475_ref40","doi-asserted-by":"crossref","first-page":"439","DOI":"10.2174\/1567205013666151116124912","article-title":"Lymphocytes in Alzheimer\u2019s disease pathology: Altered signaling pathways","volume":"13","author":"Esteras","year":"2016","journal-title":"Curr Alzheimer Res"},{"key":"10.3233\/JAD-190475_ref41","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1136\/jnnp.49.5.595","article-title":"Lymphocyte concanavalin A capping: a similarity between Down\u2019s syndrome and early onset primary degenerative dementia","volume":"49","author":"Duijndam-van den Berge","year":"1986","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.3233\/JAD-190475_ref42","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0165-5728(92)90013-B","article-title":"Abnormal expression of actin in lymphocytes of Alzheimer\u2019s disease and Down\u2019s syndrome patients","volume":"38","author":"Jabbour","year":"1992","journal-title":"J Neuroimmunol"},{"key":"10.3233\/JAD-190475_ref43","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/S1474-4422(16)00063-6","article-title":"Dementia in Down\u2019s syndrome","volume":"15","author":"Ballard","year":"2016","journal-title":"Lancet Neurol"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-190475","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:07:05Z","timestamp":1777370825000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-190475"}},"subtitle":[],"editor":[{"given":"Piotr","family":"Lewczuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,12,12]]},"references-count":43,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.3233\/jad-190475","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,12]]}}}